Lakefront Biotherapeutics (GLPGF) Interest Coverage Ratio Growth (3y) (2019 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn | 13.52% |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn | -98.43% |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn | 29.79% |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn | 44.22% |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn | 33.30% |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 202.36% |
| Dec 31, 2025 | -766.74% |
| Mar 31, 2025 | 243.33% |
| Mar 31, 2024 | 207.69% |
| Mar 31, 2023 | 108.44% |
| Dec 31, 2022 | -26.00% |
| Mar 31, 2022 | -39.50% |
| Mar 31, 2021 | -1.71% |
| Jun 30, 2020 | 194.72% |
| Mar 31, 2020 | -18.48% |
| Jun 30, 2019 | 112.58% |
| Mar 31, 2019 | 83.85% |